Apogee Therapeutics, Inc. (APGE) Dividend History

Apogee Therapeutics, Inc. (APGE) is a biopharmaceutical company focused on the development of targeted therapies for immune-mediated diseases. The company's pipeline emphasizes innovative treatments aimed at improving patient outcomes in areas such as inflammatory and autoimmune disorders.

221 Crescent St., Waltham, MA, 02453
Phone: 650-394-5230
Website: https://www.apogeetherapeutics.com

Dividend History

Apogee Therapeutics, Inc. currently does not pay dividends

Company News

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

Apogee Therapeutics reported positive 16-week data from its Phase 2 APEX clinical trial of APG777, an anti-IL-13 antibody for moderate-to-severe atopic dermatitis. The trial showed 71% reduction in EASI score and 66.9% of patients achieving EASI-75 response, with a favorable safety profile.

GlobeNewswire Inc.
Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE) By GuruFocus - Investing.com Canada

Apogee Therapeutics Inc CEO Michael Henderson sold 15,000 shares of the company, reducing his ownership to 1,474,487 shares. The transaction could be of interest to investors tracking insider behaviors as an indicator of company performance and future stock movement.

Investing.com
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Apogee (APGE) surges 95.6% in a month after reporting positive interim results from its phase I study for APG777 to treat AD. The company plans to initiate a phase II study for the same indication.

Zacks Investment Research

Featured Companies: ACET ADMA FGEN
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

As of March 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, ...

Benzinga

Featured Companies: MOH
Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky

Investors should consider this list of healthcare stocks for 2024

MarketWatch

Featured Companies: AAPL ABBV ABT ALKS AMC BHVN BSX CING CSTL DHR ENSG EXEL FTRE GME IQV ITGR LH LLY MARA NEO NTRA NVDA PFE PGNY PSCH SLP SOPH SYK TSLA XLV

Page data last updated 09/07/2025 04:04:32 UTC